Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia

BACKGROUND: Memantine has shown effects on cortical metabolism in Alzheimer’s disease (AD), and the mechanism of action may not be specific to AD alone. We hypothesized that participants with frontotemporal dementia taking memantine would show an increased cortical metabolic activity in frontal regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Tiffany W, Graff-Guerrero, Ariel, Verhoeff, Nicolaas PLG, Binns, Malcolm A, Tang-Wai, David F, Freedman, Morris, Masellis, Mario, Black, Sandra E, Wilson, Alan A, Houle, Sylvain, Pollock, Bruce G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140294/
https://www.ncbi.nlm.nih.gov/pubmed/21792308
http://dx.doi.org/10.2147/NDT.S22635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140294/
https://www.ncbi.nlm.nih.gov/pubmed/21792308
http://dx.doi.org/10.2147/NDT.S22635

Ejemplares similares